Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer.
Jin J, Wu Y, Zhao Z, Wu Y, Zhou YD, Liu S, Sun Q, Yang G, Lin J, Nagle DG, Qin J, Zhang Z, Chen HZ, Zhang W, Sun S, Luan X.
Jin J, et al. Among authors: liu s.
JCI Insight. 2022 Nov 22;7(22):e160606. doi: 10.1172/jci.insight.160606.
JCI Insight. 2022.
PMID: 36509291
Free PMC article.